CN103215222A - 一种将人脂肪间充质干细胞诱导成神经细胞的诱导培养基及方法 - Google Patents
一种将人脂肪间充质干细胞诱导成神经细胞的诱导培养基及方法 Download PDFInfo
- Publication number
- CN103215222A CN103215222A CN2013101476542A CN201310147654A CN103215222A CN 103215222 A CN103215222 A CN 103215222A CN 2013101476542 A CN2013101476542 A CN 2013101476542A CN 201310147654 A CN201310147654 A CN 201310147654A CN 103215222 A CN103215222 A CN 103215222A
- Authority
- CN
- China
- Prior art keywords
- cell
- liquid
- stem cell
- solution
- mesenchymal stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001939 inductive effect Effects 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims abstract description 34
- 230000006698 induction Effects 0.000 title abstract description 18
- 210000000577 adipose tissue Anatomy 0.000 title abstract description 14
- 210000002569 neuron Anatomy 0.000 title abstract description 6
- 210000002536 stromal cell Anatomy 0.000 title abstract 7
- 210000004027 cell Anatomy 0.000 claims abstract description 103
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims abstract description 25
- 230000004069 differentiation Effects 0.000 claims abstract description 17
- 210000000130 stem cell Anatomy 0.000 claims abstract description 16
- 239000012679 serum free medium Substances 0.000 claims abstract description 13
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 claims abstract description 12
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 claims abstract description 12
- 238000001914 filtration Methods 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims description 42
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 35
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims description 18
- 102100039289 Glial fibrillary acidic protein Human genes 0.000 claims description 13
- 101710193519 Glial fibrillary acidic protein Proteins 0.000 claims description 13
- 101001092197 Homo sapiens RNA binding protein fox-1 homolog 3 Proteins 0.000 claims description 13
- 102100035530 RNA binding protein fox-1 homolog 3 Human genes 0.000 claims description 13
- 210000005046 glial fibrillary acidic protein Anatomy 0.000 claims description 13
- 239000008886 xiangdan Substances 0.000 claims description 11
- 210000003757 neuroblast Anatomy 0.000 claims description 9
- 230000004130 lipolysis Effects 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- -1 β-TubulinIII Proteins 0.000 claims description 5
- 239000002458 cell surface marker Substances 0.000 claims description 4
- 238000003125 immunofluorescent labeling Methods 0.000 claims description 4
- 230000000877 morphologic effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 238000011156 evaluation Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 230000001186 cumulative effect Effects 0.000 claims description 2
- 239000000243 solution Substances 0.000 abstract description 17
- 102000009024 Epidermal Growth Factor Human genes 0.000 abstract description 12
- 239000003102 growth factor Substances 0.000 abstract description 10
- 239000002609 medium Substances 0.000 abstract description 8
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 abstract description 7
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 abstract description 7
- 229940077737 brain-derived neurotrophic factor Drugs 0.000 abstract description 5
- 101800003838 Epidermal growth factor Proteins 0.000 abstract description 4
- 229940116977 epidermal growth factor Drugs 0.000 abstract description 4
- 101100385253 Chiloscyllium indicum GM1 gene Proteins 0.000 abstract description 3
- 239000007924 injection Substances 0.000 abstract description 3
- 238000002347 injection Methods 0.000 abstract description 3
- 231100000252 nontoxic Toxicity 0.000 abstract description 3
- 230000003000 nontoxic effect Effects 0.000 abstract description 3
- 239000002131 composite material Substances 0.000 abstract 2
- 230000007717 exclusion Effects 0.000 abstract 1
- 150000002270 gangliosides Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 16
- 238000012258 culturing Methods 0.000 description 11
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 10
- 102000013275 Somatomedins Human genes 0.000 description 10
- 239000000411 inducer Substances 0.000 description 10
- 230000001537 neural effect Effects 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 230000001413 cellular effect Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 230000004083 survival effect Effects 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 235000011089 carbon dioxide Nutrition 0.000 description 6
- 210000003169 central nervous system Anatomy 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 238000011010 flushing procedure Methods 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 208000001738 Nervous System Trauma Diseases 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 238000010166 immunofluorescence Methods 0.000 description 4
- 208000028412 nervous system injury Diseases 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 3
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 3
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- YRQNKMKHABXEJZ-UVQQGXFZSA-N chembl176323 Chemical compound C1C[C@]2(C)[C@@]3(C)CC(N=C4C[C@]5(C)CCC6[C@]7(C)CC[C@@H]([C@]7(CC[C@]6(C)[C@@]5(C)CC4=N4)C)CCCCCCCC)=C4C[C@]3(C)CCC2[C@]2(C)CC[C@H](CCCCCCCC)[C@]21C YRQNKMKHABXEJZ-UVQQGXFZSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000000093 cytochemical effect Effects 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000007667 floating Methods 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 150000003408 sphingolipids Chemical class 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 240000007164 Salvia officinalis Species 0.000 description 2
- CWHJIJJSDGEHNS-MYLFLSLOSA-N Senegenin Chemical compound C1[C@H](O)[C@H](O)[C@@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)C(CC[C@]4(CCC(C[C@H]44)(C)C)C(O)=O)=C4[C@@H](CCl)C[C@@H]3[C@]21C CWHJIJJSDGEHNS-MYLFLSLOSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000001130 astrocyte Anatomy 0.000 description 2
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000009194 climbing Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 238000012637 gene transfection Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000007443 liposuction Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000001178 neural stem cell Anatomy 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 2
- 235000005412 red sage Nutrition 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000008354 sodium chloride injection Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000009871 tenuigenin Substances 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 102100022464 5'-nucleotidase Human genes 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 208000018152 Cerebral disease Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 230000010558 Gene Alterations Effects 0.000 description 1
- 102000006354 HLA-DR Antigens Human genes 0.000 description 1
- 108010058597 HLA-DR Antigens Proteins 0.000 description 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
- 101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 description 1
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- 102100032818 Integrin alpha-4 Human genes 0.000 description 1
- 102100025304 Integrin beta-1 Human genes 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000015336 Nerve Growth Factor Human genes 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 101710098940 Pro-epidermal growth factor Proteins 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000028600 axonogenesis Effects 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 230000024835 cytogamy Effects 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 230000002461 excitatory amino acid Effects 0.000 description 1
- 239000003257 excitatory amino acid Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000003961 neuronal insult Effects 0.000 description 1
- 230000007996 neuronal plasticity Effects 0.000 description 1
- 230000002887 neurotoxic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000004248 oligodendroglia Anatomy 0.000 description 1
- 244000138993 panchioli Species 0.000 description 1
- 210000005034 parasympathetic neuron Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101476542A CN103215222A (zh) | 2013-04-19 | 2013-04-19 | 一种将人脂肪间充质干细胞诱导成神经细胞的诱导培养基及方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101476542A CN103215222A (zh) | 2013-04-19 | 2013-04-19 | 一种将人脂肪间充质干细胞诱导成神经细胞的诱导培养基及方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103215222A true CN103215222A (zh) | 2013-07-24 |
Family
ID=48813386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013101476542A Pending CN103215222A (zh) | 2013-04-19 | 2013-04-19 | 一种将人脂肪间充质干细胞诱导成神经细胞的诱导培养基及方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103215222A (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105062970A (zh) * | 2015-08-25 | 2015-11-18 | 北京瑞思德生物医学研究院 | 一种将间充质干细胞诱导成神经细胞的诱导剂及诱导分化完全培养基 |
CN111304167A (zh) * | 2018-12-12 | 2020-06-19 | 上海泉眼生物科技有限公司 | 人源脂肪干细胞来源的神经元前体细胞及其制备方法和应用 |
CN111621525A (zh) * | 2020-06-18 | 2020-09-04 | 山东如戴生物科技有限公司 | Stx1b基因在促进人脂肪间充质干细胞生长和分化中的用途 |
CN111662878A (zh) * | 2020-06-18 | 2020-09-15 | 山东如戴生物科技有限公司 | Nudt12基因在促进人脂肪间充质干细胞生长和分化中的用途 |
CN115354029A (zh) * | 2022-08-16 | 2022-11-18 | 上海长征医院 | 神经类器官的制备方法和神经类器官 |
CN116410921A (zh) * | 2023-02-09 | 2023-07-11 | 北京益华生物科技有限公司 | 一种人源脐带间充质干细胞诱导培养基、诱导方法及应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1701787A (zh) * | 2004-05-24 | 2005-11-30 | 山东绿叶天然药物研究开发有限公司 | 丹参素在制备治疗脑血管疾病的药物中的应用 |
CN1778905A (zh) * | 2004-11-22 | 2006-05-31 | 赵春华 | 一种脂肪间充质干细胞的分离培养方法及其应用 |
CN1965075A (zh) * | 2004-04-16 | 2007-05-16 | 株式会社日立医药 | 细胞分化转换方法 |
CN101215545A (zh) * | 2007-12-31 | 2008-07-09 | 浙江大学 | 利用骨髓间充质干细胞诱导获得神经前体细胞的方法 |
-
2013
- 2013-04-19 CN CN2013101476542A patent/CN103215222A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1965075A (zh) * | 2004-04-16 | 2007-05-16 | 株式会社日立医药 | 细胞分化转换方法 |
CN1701787A (zh) * | 2004-05-24 | 2005-11-30 | 山东绿叶天然药物研究开发有限公司 | 丹参素在制备治疗脑血管疾病的药物中的应用 |
CN1778905A (zh) * | 2004-11-22 | 2006-05-31 | 赵春华 | 一种脂肪间充质干细胞的分离培养方法及其应用 |
CN101215545A (zh) * | 2007-12-31 | 2008-07-09 | 浙江大学 | 利用骨髓间充质干细胞诱导获得神经前体细胞的方法 |
Non-Patent Citations (5)
Title |
---|
于丽等: "香丹注射液诱导人脐血间充质干细胞向神经细胞的分化", 《中国组织工程研究与临床康复》, vol. 13, no. 14, 2 April 2009 (2009-04-02), pages 2656 - 2660 * |
刘斌等: "不同剂量的神经节苷脂对人脂肪组织来源的基质细胞分化为神经组织细胞的影响", 《临床神经病学杂志》, vol. 21, no. 1, 28 February 2008 (2008-02-28), pages 33 - 36 * |
刘斌等: "神经节苷脂对人脂肪基质细胞分化为神经细胞的神经递质关键酶TH、CHAT、GAD的影响", 《中国药房》, vol. 18, no. 19, 31 December 2007 (2007-12-31), pages 1495 - 1461 * |
董静等: "脂肪组织来源的基质细胞向神经细胞分化及其在脑缺血疾病治疗中的应用进展", 《中国康复医学杂志》, vol. 22, no. 11, 30 November 2007 (2007-11-30) * |
陈丹丹等: "bFGF联合香丹注射液诱导间充质干细胞向神经元样细胞分化", 《辽宁医学院学报》, vol. 32, no. 3, 30 June 2011 (2011-06-30), pages 213 - 216 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105062970A (zh) * | 2015-08-25 | 2015-11-18 | 北京瑞思德生物医学研究院 | 一种将间充质干细胞诱导成神经细胞的诱导剂及诱导分化完全培养基 |
CN105062970B (zh) * | 2015-08-25 | 2017-12-29 | 青岛瑞思科生物科技有限公司 | 一种将间充质干细胞诱导成神经细胞的诱导剂及诱导分化完全培养基 |
CN111304167A (zh) * | 2018-12-12 | 2020-06-19 | 上海泉眼生物科技有限公司 | 人源脂肪干细胞来源的神经元前体细胞及其制备方法和应用 |
CN111304167B (zh) * | 2018-12-12 | 2024-03-26 | 上海泉眼生物科技有限公司 | 人源脂肪干细胞来源的神经元前体细胞及其制备方法和应用 |
CN111621525A (zh) * | 2020-06-18 | 2020-09-04 | 山东如戴生物科技有限公司 | Stx1b基因在促进人脂肪间充质干细胞生长和分化中的用途 |
CN111662878A (zh) * | 2020-06-18 | 2020-09-15 | 山东如戴生物科技有限公司 | Nudt12基因在促进人脂肪间充质干细胞生长和分化中的用途 |
CN111621525B (zh) * | 2020-06-18 | 2021-04-23 | 中赛干细胞基因工程有限公司 | Stx1b基因在促进人脂肪间充质干细胞生长和分化中的用途 |
CN111662878B (zh) * | 2020-06-18 | 2021-12-10 | 上海汉氏方舟生物科技有限公司 | Nudt12基因在促进人脂肪间充质干细胞生长和分化中的用途 |
CN115354029A (zh) * | 2022-08-16 | 2022-11-18 | 上海长征医院 | 神经类器官的制备方法和神经类器官 |
CN115354029B (zh) * | 2022-08-16 | 2023-09-01 | 上海长征医院 | 神经类器官的制备方法和神经类器官 |
CN116410921A (zh) * | 2023-02-09 | 2023-07-11 | 北京益华生物科技有限公司 | 一种人源脐带间充质干细胞诱导培养基、诱导方法及应用 |
CN116410921B (zh) * | 2023-02-09 | 2024-01-23 | 北京益华生物科技有限公司 | 一种人源脐带间充质干细胞诱导培养基、诱导方法及应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103215222A (zh) | 一种将人脂肪间充质干细胞诱导成神经细胞的诱导培养基及方法 | |
CN101748096B (zh) | 亚全能干细胞、其制备方法及其用途 | |
CN102127522B (zh) | 人脐带间充质干细胞及其制备方法 | |
CN103153318B (zh) | 用于细胞的生物反应器放大的细胞培养系统 | |
JP6824267B2 (ja) | ヒト誘導多能性幹細胞からライディッヒ細胞への分化誘導方法及びその用途 | |
CN105132369B (zh) | 一种将间充质干细胞转化为睾酮分泌细胞的诱导剂及诱导培养基 | |
CN102443566A (zh) | 一种脂肪干细胞的获取方法 | |
CN103881971B (zh) | 一种用于培养和/或扩增间充质干细胞的培养基及其培养方法 | |
CN103087977A (zh) | 一种体外高效扩增动物细胞的培养液及其用途 | |
CN108300690A (zh) | 一种脂肪间充质干细胞的分离培养方法和无血清培养基 | |
CN103756954A (zh) | 一种将人脂肪间充质干细胞诱导成胰岛素分泌细胞的诱导剂、诱导培养基及方法 | |
CN106350480B (zh) | 一种纯化牛胎儿骨骼肌组织来源成肌细胞的方法 | |
CN106282100A (zh) | 一种纯化牛胎儿骨骼肌组织来源前体脂肪细胞的方法 | |
CN105062970B (zh) | 一种将间充质干细胞诱导成神经细胞的诱导剂及诱导分化完全培养基 | |
CN109694851A (zh) | 一种人间充质干细胞的诱导组合物、诱导分化培养液及其体外诱导方法和应用 | |
CN105850979A (zh) | 一种骨髓间充质干细胞的冻存保护液及冻存方法 | |
CN109266610A (zh) | 一种促进间充质干细胞分化为神经元的方法 | |
CN107287156A (zh) | 一种脂肪间充质干细胞的分离培养方法及其应用 | |
CN105255824A (zh) | 一种牙周膜干细胞成骨分化诱导液及方法 | |
CN103387959A (zh) | 一种乳牙干细胞及其制备方法和应用 | |
CN101531996A (zh) | 源于成形组织的间充质干细胞的分离和纯化方法 | |
KR20180067330A (ko) | 인간 만능줄기세포로부터 중간엽 줄기세포로의 분화 유도 생산율을 증가시키는 방법 및 이에 의해 생성된 중간엽 줄기세포 | |
CN105112367B (zh) | 一种间充质干细胞表皮分化诱导剂及其应用方法 | |
CN101054572B (zh) | 人脐血干细胞培养及定向分化为多巴胺能神经细胞的方法及得到的多巴胺能神经细胞的应用 | |
CN103184190A (zh) | 一种将脂肪干细胞转化为睾酮分泌细胞的诱导剂及培养基 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO RUISIDE BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: CHEN YUNYAN Effective date: 20131231 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Haiying Inventor after: Yang Shengbao Inventor after: Yu Li Inventor after: Chen Yunyan Inventor after: Wang Qinghua Inventor after: Zhang Bingqiang Inventor before: Liu Haiying Inventor before: Yang Shengbao Inventor before: Yu Li Inventor before: Chen Yunyan Inventor before: Wang Qinghua |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU HAIYING YANG SHENGBAO YU LI CHEN YUNYAN WANG QINGHUA TO: LIU HAIYING YANG SHENGBAO YU LI CHEN YUNYAN WANG QINGHUA ZHANG BINGQIANG Free format text: CORRECT: ADDRESS; FROM: 266000 QINGDAO, SHANDONG PROVINCE TO: 266700 QINGDAO, SHANDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20131231 Address after: Room A-130 Qingdao National University Science Park 127 No. 266700 Shandong city of Qingdao province high tech Industrial Development Zone wise Bridge Applicant after: QINGDAO RE-STORE BIOTECH CO., LTD. Address before: 266000, No. 3, building 28, building 417, 601 Yang Xing Road, Chengyang District, Shandong, Qingdao Applicant before: Chen Yunyan |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130724 |